Jury finds for Merck in hepatitis drug fight with Gilead
A federal jury in California has ruled in favor of drugmaker Merck & Co. in a high-stakes lawsuit against rival Gilead Sciences Inc. over patents for lucrative new drugs that rapidly cure hepatitis C.
Mar 22, 2016
0
2